FDA inspection
BioAccess, Inc.: FDA inspection ending Aug 20, 2024
FDA inspection 1246993 · Voluntary Action Indicated (VAI) · Baltimore, MD
Key facts
| Inspection ID | 1246993 |
|---|---|
| Firm | BioAccess, Inc. |
| FEI number | 1000513050 |
| Address | 3600 Odonnell St Ste 300 |
| City | Baltimore |
| State | MD |
| ZIP | 21224 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Aug 20, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data